The acquisition is set to give GSK ownership of three drug candidates for lung cancer, two of which are under FDA review for approval this year.
Source link
GSK to Buy Nuvalent for $10.6 Billion in Oncology Push
Date:
More like thisRelated
Cornell rape accuser’s attorney says the school and law enforcement failed a young woman
The attorney representing a former Cornell University student who...
Fa’avae earns Mountain West Freshman of the Week as Lobos turn attention to UTEP
ALBUQUERQUE, N.M. (KRQE) – The Chile roaster remains in...
Legrand Shares Rise After Data-Center Boom Prompts Guidance Upgrade
Legrand shares climbed after the French supplier of electrical...